WEIGHT RESET 

Achieve sustainable weight loss with compounded GLP-1 medications – scientifically proven to curb cravings and control appetite. Lose up to 15-20% of your body weight without extreme diets or intense workouts

Semaglutide+Glycine+B12

$425/month

A powerful GLP-1 therapy for medical weight loss


Semaglutide mimics the body’s natural GLP-1 hormone to reduce appetite, improve blood sugar control, and support sustainable fat loss. Available as Ozempic® and Wegovy®, patients may lose up to 15% of body weight.

✔️ Once-weekly injection
✔️ Proven appetite control
✔️ Supports A1C + metabolic health

Book it

Tirzepatide+Glycine+B12

$600/month

The next-generation GLP-1 + GIP therapy for advanced weight loss


Tirzepatide is a dual-action GLP-1 + GIP medication that reduces appetite, improves insulin response, and accelerates fat loss. Sold as Mounjaro® and Zepbound®, it has helped patients lose up to 20% of body weight.

✔️ Greater weight loss than Semaglutide
✔️ Dual-hormone appetite control
✔️ Supports A1C + metabolic health

book it

*Medical consultation and lab review required to assess eligibility before starting the program

What Makes Our Weight Loss Injections Different?

Our clinically supervised GLP-1 therapy enhances standard treatment with Glycine + B12 to support fat loss, energy, and metabolic function. Available in-clinic or at home, with expert monitoring to ensure precise dosing, minimized side effects, and optimized results.

✔️ Glycine — Supports muscle preservation
✔️ B12 — Helps prevent fatigue
✔️ Clinically Supervised — Personalized oversight
✔️ Optimized Results — Sustainable, science-driven weight loss

Benefits

Appetite Regulation

Reduces hunger signals and improves portion control.

Fat Loss Support

Promotes gradual, sustainable body fat reduction.

Blood Sugar Balance

Supports insulin sensitivity and glucose regulation.

Cardiometabolic Health

May support cholesterol, inflammation, and heart health markers.

Reduced Cravings

Helps quiet “food noise” and emotional eating triggers.

Long-Term Weight Management

Supports sustainable results when paired with lifestyle changes.

Which one is better for you?

  • Semaglutide

    GLP-1 receptor agonist

    Tirzepatide

    Dual agonist (GLP-1 & GIP receptors)

  • Semaglutide

    Up to 15-20% of body weight

    Tirzepatide

    Up to 22.5% of body weight

  • Semaglutide

    Nausea, stomach discomfort, possible pancreatitis risk

    Tirzepatide

    Nausea, diarrhea, vomiting (more GI side effects)

Timeline

Week 1

Appetite reduction and improved portion control may begin. Some clients notice early changes in cravings and food “noise.” Mild nausea or GI changes can occur as your body adjusts.

Weeks 2–4

Steadier appetite control and improved satiety become more consistent. Weight loss may begin gradually, especially with protein-forward nutrition and hydration support.

Weeks 4–8

With appropriate dose titration, many clients experience more noticeable body composition changes. Energy and metabolic markers may improve with lifestyle alignment and resistance training.

Weeks 8–12+

Cumulative progress may include sustained fat loss, improved metabolic health, and better long-term appetite regulation. Ongoing success is optimized with consistent habits and follow-up support.

Ideal For

  • Clients with medical overweight/obesity looking for appetite support
  • Persistent cravings or “food noise” impacting consistency
  • Metabolic optimization goals alongside nutrition + movement
  • Insulin resistance or elevated A1c risk (provider-evaluated)
  • Need for structured support + coaching for long-term results
  • Difficulty sustaining a calorie deficit despite good effort
  • Cardiometabolic health goals with monitoring
  • Those who want gradual, medically guided fat-loss support

Not Suitable For

  • Pregnant, breastfeeding, or trying to conceive
  • Personal/family history of medullary thyroid cancer or MEN2
  • History of pancreatitis (provider-evaluated risk/clearance)
  • Severe GI disease (e.g., gastroparesis) or severe reflux issues
  • Significant gallbladder disease without evaluation/clearance
  • Uncontrolled eating disorder history (requires coordination of care)
  • Type 1 diabetes (requires specialist management)
  • Anyone who cannot be appropriately medically screened/monitored

FAQs

  • GLP-1 medications mimic the body’s natural satiety hormone to regulate appetite, improve blood sugar balance, and support medically guided weight loss.

  • Yes. Semaglutide (Ozempic®, Wegovy®) and Tirzepatide (Mounjaro®, Zepbound®) are FDA-approved for diabetes and/or chronic weight management. Compounded versions are not FDA-approved but may be prescribed and prepared by regulated compounding pharmacies.

  • Yes. Baseline labs are required to assess metabolic health and safety. Common labs include A1C, fasting glucose, CMP, lipid panel, and thyroid markers when indicated.

  • The most common include nausea, constipation, diarrhea, bloating, acid reflux, decreased appetite, and mild fatigue—especially during early dose escalation.

Disclosure:

Weight management therapies at Drip Alchemy include compounded medications prepared by a licensed U.S. pharmacy pursuant to a provider prescription. These therapies are widely utilized in integrative and medical wellness settings to support metabolic health, appetite regulation, and body composition goals.

Compounded medications are not evaluated or approved by the U.S. Food and Drug Administration.